Master Lecture Overview: Ultrasound Literacy, Percutaneous Repair, and The Future of Shoulder Surgery

Speaker Profile, Academic Pedigree & Disclosures

• Speaker Identity: Dr. Alexander Lädermann, MD (Geneva, Switzerland).
• Primary Positions:
  • Privatdozent (PD) at the University of Geneva.
  • Chief Executive Officer (CEO) of BeeMed (orthopedic educational platform).
  • Former clinical and research fellow under Dr. Stephen S. Burkhart (San Antonio, Texas).
• Leadership Roles:
  • Past President of the Swiss Shoulder and Elbow Society.
  • President of the FORE Group (Foundation for Orthopaedic Research and Education).
  • Member of the Membership and Central Committees of SECEC (European Society for Surgery of the Shoulder and the Elbow).
  • Member of the Central Committee of the French Arthroscopy Society (SFA).
  • Chairman of the Advanced Course on Shoulder Arthroscopy.
  • President of the SECEC Congress held in Geneva.
  • President of the International Congress on Adipose Stem Cell Treatment in Zurich.
  • Associate Editor of the Journal of Shoulder and Elbow Arthroplasty.
• Disclosures & Conflicts:
  • Consultant for Arthrex, Stryker, and Medacta.
  • Recipient of research royalties.
  • Stated that commercial relationships did not influence presentation content.

Industrial vs. Surgical Innovation Cycles

• The Geneva Motor Show Metaphor:
  • Automotive marketing consistently promises yearly “revolutions” (e.g., Paris Motor Show 2022).
  • The automobile industry actually saw 126 years of minor, incremental evolution without a fundamental mechanical disruption until electric vehicles emerged around 2012.
• The Trajectory of Arthroscopic Surgery:
  • Joint arthroscopy began as a genuine surgical disruption roughly 55 to 56 years ago.
  • The specialty has since plateaued into 5+ decades of small, incremental adjustments without major paradigm shifts.
  • Operating rooms remain reliant on expensive, high-footprint equipment (fluid towers, RF ablation units, shavers, optical scopes, fluid pumps).
  • Technical execution of key procedures (e.g., subscapularis tendon repair) has remained largely unchanged for over 20 years.
• Existential Crisis of Societies: Major arthroscopic societies struggle to maintain engagement because modern academic meetings showcase minor technique modifications rather than clinical breakthroughs.

Disruptive Technology & Historical Precedents

• Definition of Disruptive Technology: An innovation that causes a rapid, irreversible paradigm shift, rendering entrenched standard practices obsolete.
• Key Historical Disruptions in Surgery:
  • General Anesthesia: Abolished surgical shock, pain, and physiological exhaustion.
  • Electric Lighting: Moved surgery indoors from open-air courtyards, eliminating the fire risks of open flame lanterns around volatile anesthetic vapors (e.g., ether) and significantly reducing surgical site infections.
  • Arthroscopy: Replaced large, destructive open arthrotomies with low-morbidity optical visualization.
• Skepticism Toward New Technologies:
  • Established authorities routinely reject disruptive tools due to fear of new complications, unproven equipment costs, and perceived inaccuracies.
  • Dr. Charles Neer famously declared the arthroscope to be the “instrument of the devil.”
  • This pushback heavily influenced pioneers like Dr. Stephen Burkhart, who spent years validating arthroscopic outcomes.
• The French Rheumatology Precedent:
  • In the 1970s and 1980s, French orthopedic surgeons resisted diagnostic and operative arthroscopy.
  • Rheumatologists rapidly purchased scopes and established early clinical leadership over joint assessments.
  • French orthopedic surgeons spent more than a decade actively working to reclaim procedural control of joint endoscopy.

The Cardiovascular Precedent: A Cautionary Warning

• The Interventional Cardiology Disruption:
  • Cardiac surgeons historically dominated coronary revascularization via open coronary artery bypass grafting (CABG).
  • Surgeons initially dismissed catheter-based, image-guided endovascular techniques as transient or inadequate.
  • Interventional cardiologists and radiologists embraced percutaneous transluminal angioplasty and coronary stenting.
• The Specialty Shift:
  • Open CABG procedural volume dropped drastically worldwide.
  • Non-surgeons captured the dominant share of procedural volume and reimbursement.
• The Orthopedic Parallel: Orthopedic surgeons risk similar obsolescence if they stay anchored to hospital-based arthroscopic towers while non-surgeons develop office-based, needle-guided alternatives.

The Biological Fallacy of Delayed Rotator Cuff Repair

• The Paradox of Delayed Surgery: Approximately 60% of Dr. Lädermann’s practice involves rotator cuff procedures; he describes standard practice as waiting until clinicians must attempt to “make rotten tendon heal onto osteoporotic bone.”
• The Cutaneous Melanoma Analogy:
  • Clinicians do not leave a primary malignant melanoma in place to wait for metastatic spread before initiating therapy.
  • In rotator cuff management, practice patterns often observe repairable partial or small full-thickness tears until severe retraction, muscle fatty degeneration, and bone osteopenia develop.
• The Biological Cascade of Delay:
  • Tendon Retraction: Dominik Meyer demonstrated that increased medial tendon edge retraction directly degrades structural healing rates.
  • Muscular Fatty Degeneration (Arnaud Godenèche 10-Year Study):
    • Goutallier Stage 0: 90% intact tendon continuity and clinical success at 10-year follow-up.
    • Goutallier Stage 1: Anatomical continuity drops to 78%.
    • Goutallier Stage 2: Structural success falls to 69%.
  • Early Muscle Edema & Fibrosis: Recent trials demonstrate that muscle edema and irreversible myofibroblastic pathways emerge within 3 weeks following an acute traumatic cuff disruption.
• The Downstream Costs of Conservative Management:
  • Physical therapy regimens frequently accumulate up to $4,000 per episode.
  • Routine serial MRI tracking costs approximately $750 per scan in Geneva.
  • Unproven biologic injections (e.g., stem cells) can cost up to $10,000 without definitive clinical validation.
  • Indirect economic costs: Long-term sick leave, disability payments, and progressive loss of workplace productivity.
  • Downstream salvage interventions: Dermal allografts, porcine xenografts, polyethylene terephthalate (PET) patches, Teflon sheets, subacromial balloons, complex tendon transfers, and reverse total shoulder arthroplasties.
• The Long-Term Clinical Evidence: The Smout & Mario prospective trial comparing early primary surgical repair against non-operative therapy demonstrated clear clinical superiority for early structural intervention.
• Swiss Healthcare Policy Crisis (2019): The Swiss Medical Board challenged the Swiss Orthopedic Society with systematic reviews favoring non-operative management, threatening to de-list arthroscopic cuff repair from national reimbursement schedules.

Encroachment by Non-Surgical Specialties

• Economic Drivers for Non-Surgeons:
  • Diagnostic Radiologists: Facing ongoing cuts to advanced imaging (MRI/CT) reimbursement and the rise of artificial intelligence diagnostic tools that reduce conventional reading income.
  • Sports Physicians & Rheumatologists: Seeking reproducible, high-reimbursement office procedures that do not require hospital operating suites.
• The Non-Surgical Procedural Timeline: Non-operative specialists have built an interventional foundation across sports medicine literature:
  • British Journal of Sports Medicine (BJSM): Published technique blueprints in 2010, 2011, and 2014.
  • Clinical Journal of Sport Medicine (CJSM): Validated office-based percutaneous interventions.
  • KSSTA: Published 2024–2025 data establishing the feasibility of percutaneous needle-based tendon repairs.
• The Procedural Expansion Progression:
  • Established In-Office Procedures: Dynamic diagnostic ultrasound, subacromial corticosteroid injections, barbotage for calcific tendinitis, capsular hydrodilatation for frozen shoulder, and percutaneous long head of biceps (LHB) tenotomy.
  • Near-Future In-Office Pipeline: Percutaneous LHB tenodesis, percutaneous PASTA repair, needle-based Hill-Sachs remplissage, and minimally invasive capsular plication.

Technical Mechanics: Percutaneous Ultrasound-Guided Cuff Repair

• Operative Environment: Performed in a standard clinical examination room under local anesthesia, eliminating operating room overhead, general anesthesia, and fluid management systems.
• Step-by-Step Procedure:
  • High-frequency ultrasound probes dynamically map the footprint and tear margins in real time.
  • A small-gauge handheld bone punch perforates the footprint cortex via manual axial pressure without surgical mallets.
  • Low-profile, expandable subcortical micro-anchors pass through the needle track beneath the cortical bone bridge.
  • Specialized needles shuttle suture limbs through the torn supraspinatus/infraspinatus tendon.
  • Suture limbs are tensioned and locked percutaneously, securing the tendon down to the bleeding cortical bone bed.
• Cross-Anatomical Applications: Similar ultrasound-guided needle-anchor systems are being applied to extensor carpi radialis brevis tendinopathy (tennis elbow), plantar fascia release, Achilles tendinopathy debridement, and patellar tendinopathy.

Dr. Lädermann’s Personal Practice Patterns (Geneva)

• Integrated Point-of-Care Ultrasound (POCUS):
  • Routine dynamic diagnostic ultrasound used for all initial outpatient consultations.
  • Weekly protected fellowship clinic days dedicated to fellow-administered diagnostic ultrasound and needle-guided procedures.
  • Routine intraoperative ultrasound localization of calcific tendinopathy deposits.
  • Routine dynamic ultrasound checks performed on all operative repairs at 6 months post-op to verify tendon healing.
  • In-office percutaneous tenotomy of the long head of the biceps.
• Biologic Therapeutics & Injections:
  • Platelet-Rich Plasma (PRP): Completely discontinued for interstitial and partial rotator cuff tears based on the author’s AJSM trial, which showed no clinical benefit over saline alongside higher complication rates and elevated patient costs; not reimbursed by Swiss insurance.
  • Stem Cell Therapy: Not used clinically due to strict regulatory restrictions in Switzerland.
  • Hyaluronic Acid: Not reimbursed for shoulder pathology; patients desiring therapy are referred out.
  • Primary Injectable: Targeted corticosteroid injections under direct, dynamic ultrasound visualization.
• Personal Case Study (The Speaker’s Shoulder):
  • Sustained a partial articular supraspinatus tendon avulsion (PASTA lesion) while playing tennis in 2012.
  • Chose non-operative management to avoid the morbidity of standard arthroscopy and discontinued tennis.
  • Monitors the shoulder with annual ultrasound exams; plans to undergo percutaneous needle repair once commercial systems become widely available, reserving standard arthroscopy for full-thickness progression.

Actionable Strategy for Orthopedic Surgery

• Establish Ultrasound Literacy as Foundational: Transition musculoskeletal ultrasound from an optional subspecialty interest to a mandatory core requirement in residency and fellowship training.
• Implement Objective Credentialing: Scientific bodies (e.g., SECEC, SFA, AAOS) must develop standardized curricula, practical examination tracks, and procedural volume requirements for musculoskeletal ultrasound.
• Shift Surgical Mindset from Macro to Micro: Actively develop and adopt needle-based, image-guided percutaneous repair systems rather than ceding office-based interventional care to adjacent specialties.
• Intervene Early in the Biological Timeline: Treat structural cuff defects early in the disease process before irreversible muscle retraction, fatty infiltration, and secondary joint destruction take place.